Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-07 Ring Christine General Counsel Option exercise +3,200 $1.86 $6K 4,486
2021-09-07 Ring Christine General Counsel Sale −3,200 $35.25 $113K 1,286
2021-09-07 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −3,200 107,666
2021-09-07 Hansen Gwenn Chief Scientific Officer Option exercise +1,600 $7.26 $12K 15,797
2021-09-07 Hansen Gwenn Chief Scientific Officer Sale −1,600 $35.00 $56K 14,197
2021-09-07 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −1,600 69,466
2021-09-01 Hansen Gwenn Chief Scientific Officer Option exercise +400 $7.26 $3K 14,597
2021-09-01 Hansen Gwenn Chief Scientific Officer Sale −400 $32.34 $13K 14,197
2021-09-01 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −400 71,066
2021-08-10 Ring Christine General Counsel Option exercise +1,200 $1.86 $2K 2,005
2021-08-10 Ring Christine General Counsel Sale −1,200 $29.87 $36K 805
2021-08-10 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −1,200 110,866

Page 32 of 32 · 632 trades